0
Want this question answered?
Be notified when an answer is posted
Add your answer:
Earn +20 pts
Is latuda a benzodiazepine?
No it is not
What are harmful side effects of latuda?
Some of the harmful side effects of Latuda include vomiting, dizziness, agitation, and shaking.
What is the benzisoxidil group?
composed of resperidone (Resperidal) and ziprasidone (Geodon). Resperidone has been found useful for controlling bipolar mood disorder, while ziprasidone is used primarily as second-line treatment for schizophrenia.
Latuda 40mg Can You Cut It In Half?
No just ask your doctor for some.
What should Latuda not be taken with?
This new antipsychotic, lurasidone (brand name = Latuda) is designed for treatment of symptoms of schizophrenia. It is metabolized by the cytochrome p450 system 3A4. It should not be taken with medications such as ketoconazole or rifampicin, or with grapefruit juice.
In treatment of chronic schizophrenia is there really difference in effectiveness between resperidone 4 mg daily and invega 3 mg daily when resperidone not effectively control paranoid thoughts?
There are a few treatments for Chronic Schizophrenia. The main treatment would be pills.
Is resperidone any role inparanoid schizophrenia?
Respiridone can improve the mental sicknesss in paranoid syzophrenia
How much does a month's supply of Latuda cost without insurance?
At wal-mart its $476.00 for a 30 day script.
Can you overdose on cinnamon?
no you can not overdose on cinnamon
What happened if you overdose on vitamins for multiple sclerosis?
It doesn't matter why you're taking the vitamins, an overdose is an overdose. What happens depends on which specific vitamin you overdose on.
Can you overdose on glucose?
what are the effects of overdose glucose and what are the treaments
Is Latuda ever prescribed for Bipolar?
Latuda (lurasidone) is sometime prescribed for bipolar disorder as are many other antipsychotics. In fact, there is recent data that lurasidone may be effective in the treatment of bipolar depression with no weight gain. This data has not yet been reviewed by the FDA. This data was presented at the 165th Annual APA Meeting in May 2012 by Loebel A. et al.
